Dermatology Diagnostic Devices Market Size, Share, Demand, Report, Forecast 2024-2032

1
Global Dermatology Devices Market Research and
Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• IMARC Group is a global management consulting
  firm that helps the worlds most ambitious
  changemakers to create a lasting impact. Across
  the six major continents and 100 countries, we
  work alongside our business partners as one team
  with a common ambition to achieve unparallelled
  results, gain a competitive edge, and transform
  industries. IMARC Group excels in understanding
  its clients business priorities and delivering
  tailored solutions that drive meaningful
  outcomes. Our client base spans over 3,000
  organizations in the private, public, and social
  sectors, ranging from high-growth startups to
  Fortune 500 companies.
• We provide a comprehensive suite of market entry
  and expansion services. Our offerings include
  thorough market assessment, feasibility studies,
  company incorporation assistance, factory setup
  support, regulatory approvals and licensing
  navigation, branding, marketing and sales
  strategies, competitive landscape and
  benchmarking analyses, pricing and cost research,
  and procurement research. These services are
  designed to assist companies in evaluating market
  opportunities, setting up new entities,
  navigating regulatory landscapes, boosting brand
  visibility, analyzing competitors, and optimizing
  procurement strategies.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Dermatology Devices Market Industry
  Trends, Share, Size, Growth, Opportunity and
  Forecast 2024-2032," The global dermatology
  devices market size reached US 16.1 Billion in
  2023.
• Rising prevalence of skin disorders
• Skin conditions such as acne, psoriasis, eczema,
  and skin cancer are increasingly common,
  affecting millions of individuals worldwide.
  Factors such as changes in lifestyle,
  environmental pollution, and genetic
  predispositions contribute to the growing
  incidence of these disorders. Dermatology devices
  play a crucial role in diagnosing, treating, and
  managing various skin conditions. For instance,
  devices like dermatoscopes aid in the early
  detection of skin cancer, while lasers and
  light-based therapies offer effective treatment
  options for conditions like acne and pigmentation
  disorders. As awareness about skin health grows
  and diagnostic capabilities improve, the demand
  for advanced dermatology devices continues to
  rise, particularly in regions with aging
  populations and increasing healthcare
  expenditures.
• Technological advancements in dermatological
  treatments
• Innovations in medical devices, such as laser
  systems, intense pulsed light (IPL) devices, and
  radiofrequency devices, have revolutionized the
  field of dermatology. These technologies provide
  non-invasive or minimally invasive solutions for
  skin rejuvenation, hair removal, scar revision,
  and tattoo removal, among other cosmetic and
  therapeutic procedures. Advanced imaging
  techniques, such as optical coherence tomography
  (OCT) and multispectral imaging, enable
  dermatologists to visualize skin structures with
  high resolution and accuracy,

4
Report Highlight and Description

• aiding in diagnosis and treatment planning.
  Moreover, the integration of artificial
  intelligence (AI) and machine learning (ML)
  algorithms enhances the precision and efficacy of
  dermatological treatments by analyzing patient
  data and optimizing treatment outcomes,
  bolstering the market growth.
• Increasing demand for aesthetic procedures
• Cosmetic dermatology procedures, including facial
  rejuvenation, body contouring, and skin
  tightening, have gained popularity worldwide.
  Patients seek dermatological treatments to
  improve their appearance, address signs of aging,
  and enhance self-esteem. Dermatology devices such
  as lasers, energy-based devices, and injectables
  like botulinum toxin and dermal fillers offer
  minimally invasive or non-invasive solutions with
  minimal downtime and natural-looking results. The
  growing acceptance of aesthetic procedures among
  both men and women across different age groups
  contributes to the market expansion. Moreover,
  advancements in device technology that offer
  safer, more precise, and customizable aesthetic
  treatments are contributing to the market
  expansion.
• Looking forward, IMARC Group expects the market
  to reach US 34.4 Billion by 2032, exhibiting a
  growth rate (CAGR) of 8.6 during 2024-2032.
• Request for a PDF sample of this report
• https//www.imarcgroup.com/dermatology-devices-mar
  ket/requestsample

5
Report Description

• Global Dermatology Devices Market Trends
• The expanding elderly population globally
  increases the demand for devices targeting
  age-related skin conditions such as wrinkles, age
  spots, and sagging skin, fostering the adoption
  of innovative dermatological technologies and
  treatments is aiding market growth. In line with
  this, the growing consumer awareness and
  preference for non-invasive or minimally invasive
  cosmetic procedures are driving demand for
  devices that offer effective solutions with
  reduced risks, shorter recovery times, and
  natural-looking results compared to traditional
  surgical options, creating a positive outlook for
  market expansion.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/dermatology-devices-mar
  ket

6
Report Segmentation

• Breakup by Type
• Diagnostic Devices
• Dermatoscopes
• Imaging Devices
• Others
• Treatment Devices
• Lasers
• IPL Devices
• RF Devices
• Microdermabrasion Devices
• Others
• Breakup by End-User
• Hospitals
• Specialty Dermatology Clinics
• Private Clinics

7
Report Segmentation

• Breakup by Application
• Skin Cancer
• Skin Rejuvenation
• Acne Treatment
• Hair Removal
• Others
• Breakup by Region
• North America (United States, Canada)
• Asia Pacific (China, Japan, India, Australia,
  Indonesia, South Korea, Others)
• Europe (Germany, France, United Kingdom, Italy,
  Spain, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

8
Competitive Landscape

• Abbott Diagnostics
• Strata Skin Sciences
• Roche Diagnostics
• Alma Lasers GmbH
• Cutera, Inc.
• Syneron Medical Ltd.
• 3Gen
• Aesthetic Group
• Lumenis, Ltd.
• Genesis Biosystems, Inc.

9
Key Questions Answered in the Report
10
Key Questions Answered in the Report
Who are the key players/companies in the global
dermatology devices market?
11
Table of Contents
1. Preface 2. Scope and Methodology 2.1.
Objectives of the Study 2.2.
Stakeholders 2.3. Data Sources 2.3.1.
Primary Sources 2.3.2. Secondary Sources 2.4.
Market Estimation 2.4.1. Bottom-Up
Approach 2.4.2. Top-Down Approach 2.5.
Forecasting Methodology 3. Executive
Summary 4. Global Dermatology Devices Market
Introduction 4.1. What are Dermatology
Devices 4.1.1. Introduction 4.1.2. Major
Applications 4.2. Industry Trends 4.3.
Competitive Intelligence 5. Global
Dermatology Devices Market Landscape 5.1.
Historical and Current Market Trends
(2018-2023) 5.2. Market Forecast
(2024-2032) 6. Global Dermatology Devices
Market - Breakup by Type 6.1. Diagnostic
Devices 6.1.1. Overview 6.1.2. Historical
and Current Market Trends (2018-2023)
12
Table of Contents
6.1.3. Diagnostic Devices Market -Breakup by
Type 6.1.3.1. Dermatoscopes 6.1.3.2.
Imaging Devices 6.1.3.3. Others 6.1.4.
Market Forecast (2024-2032) 6.1.5. Market
Breakup by End-User 6.1.6. Market Breakup by
Application 6.1.7. Key Players 6.1.8.
Patent Analysis 6.1.8.1. Top Patent
Applications 6.1.8.2. Document Type 6.1.8.3.
Jurisdiction Analysis 6.1.8.4. Top CPC
Codes 6.1.8.5. Legal status 6.2.
Treatment Devices 6.2.1. Overview 6.2.2.
Historical and Current Market Trends
(2018-2023) 6.2.3. Diagnostic Devices Market
-Breakup by Type 6.2.3.1. Lasers 6.2.3.2.
IPL Devices 6.2.3.3. RF Devices 6.2.3.4.
Microdermabrasion Devices 6.2.3.5.
Others 6.2.4. Market Forecast
(2024-2032) 6.2.5. Market Breakup by End-User
6.2.6. Market Breakup by Application 6.2.7.
Key Players 6.2.8. Patent Analysis 6.2.8.1.
Top Patent Applications 6.2.8.2. Document
Type 6.2.8.3. Jurisdiction Analysis
13
Table of Contents
6.2.8.4. Top CPC Codes 6.2.8.5. Legal
status 6.3. Attractive Investment Proposition
by Type 7. Global Dermatology Devices Market
- Breakup by End-User 7.1. Hospitals 7.1.1.
Overview 7.1.2. Historical and Current Market
Trends (2018-2023) 7.1.3. Market Breakup by
Type 7.1.4. Market Breakup by
Application 7.1.5. Market Forecast
(2024-2032) 7.2. Specialty Dermatology
Clinics 7.2.1. Overview 7.2.2. Historical
and Current Market Trends (2018-2023) 7.2.3.
Market Breakup by Type 7.2.4. Market Breakup
by Application 7.2.5. Market Forecast
(2024-2032) 7.3. Private Clinics 7.3.1.
Overview 7.3.2. Historical and Current Market
Trends (2018-2023) 7.3.3. Market Breakup by
Type 7.3.4. Market Breakup by
Application 7.3.5. Market Forecast
(2024-2032) 7.4. Attractive Investment
Proposition by End-User 8. Global Dermatology
Devices Market - Breakup by Application 8.1.
Skin Cancer 8.1.1. Overview 8.1.2.
Historical and Current Market Trends
(2018-2023) 8.1.3. Market Breakup by Type
14
Table of Contents
8.1.4. Market Breakup by End User 8.1.5.
Market Forecast (2024-2032) 8.2. Skin
Rejuvenation 8.2.1. Overview 8.2.2.
Historical and Current Market Trends
(2018-2023) 8.2.3. Market Breakup by
Type 8.2.4. Market Breakup by End User 8.2.5.
Market Forecast (2024-2032) 8.3. Acne
Treatment 8.3.1. Overview 8.3.2. Historical
and Current Market Trends (2018-2023) 8.3.3.
Market Breakup by Type 8.3.4. Market Breakup
by End User 8.3.5. Market Forecast
(2024-2032) 8.4. Hair Removal 8.4.1.
Overview 8.4.2. Historical and Current Market
Trends (2018-2023) 8.4.3. Market Breakup by
Type 8.4.4. Market Breakup by End User 8.4.5.
Market Forecast (2024-2032) 8.5.
Others 8.5.1. Overview 8.5.2. Historical
and Current Market Trends (2018-2023) 8.5.3.
Market Breakup by Type 8.5.4. Market Breakup
by End User 8.5.5. Market Forecast
(2024-2032) 8.6. Attractive Investment
Proposition by Application
15
Table of Contents
9. Global Dermatology Devices Market Breakup
by Region 9.1. North America 9.1.1. United
States 9.1.1.1. Patient Cases by
Indication 9.1.1.1.1. Skin Cancer 9.1.1.1.2.
Psoriasis 9.1.1.1.3. Acne 9.1.1.2.
Market Drivers 9.1.1.3. Historical and Current
Market Trends (2018-2023) 9.1.1.4. Market
Breakup by Type 9.1.1.5. Market Breakup by
End-User 9.1.1.6. Market Breakup by
Application 9.1.1.7. Key Players 9.1.1.8.
Market Forecast (2024-2032) 9.1.1.9. Recent
Investments 9.1.1.9.1. Government
Investments 9.1.1.9.2. Private
Investments 9.1.1.10. Regulatory Approval
Process 9.1.1.11. Pricing Analysis 9.1.2.
Canada 9.1.2.1. Market Drivers 9.1.2.2.
Historical and Current Market Trends
(2018-2023) 9.1.2.3. Market Breakup by
Type 9.1.2.4. Market Breakup by
End-User 9.1.2.5. Market Breakup by
Application 9.1.2.6. Key Players 9.1.2.7.
Market Forecast (2024-2032) 9.1.2.8. Recent
Investments 9.1.2.8.1. Government Investments
16
Table of Contents
9.1.2.8.2. Private Investments 9.1.2.9.
Regulatory Approval Process 9.1.2.10. Pricing
Analysis 9.2. Europe 9.2.1.
Germany 9.2.1.1. Patient Cases by
Indication 9.2.1.1.1. Skin Cancer 9.2.1.1.2.
Psoriasis 9.2.1.1.3. Acne 9.2.1.2.
Market Drivers 9.2.1.3. Historical and Current
Market Trends (2018-2023) 9.2.1.4. Market
Breakup by Type 9.2.1.5. Market Breakup by
End-User 9.2.1.6. Market Breakup by
Application 9.2.1.7. Key Players 9.2.1.8.
Market Forecast (2024-2032) 9.2.1.9. Recent
Investments 9.2.1.9.1. Government
Investments 9.2.1.9.2. Private
Investments 9.2.1.10. Regulatory Approval
Process 9.2.1.11. Pricing Analysis 9.2.2.
France 9.2.2.1. Patient Cases by
Indication 9.2.2.1.1. Skin Cancer 9.2.2.1.2.
Psoriasis 9.2.2.1.3. Acne 9.2.2.2.
Market Drivers 9.2.2.3. Historical and Current
Market Trends (2018-2023) 9.2.2.4. Market
Breakup by Type 9.2.2.5. Market Breakup by
End-User
17
Table of Contents
9.2.2.6. Market Breakup by Application 9.2.2.7.
Key Players 9.2.2.8. Market Forecast
(2024-2032) 9.2.2.9. Recent Investments 9.2.2.9
.1. Government Investments 9.2.2.9.2.
Private Investments 9.2.2.10. Regulatory
Approval Process 9.2.2.11. Pricing Analysis
9.2.3. United Kingdom 9.2.3.1. Patient
Cases by Indication 9.2.3.1.1. Skin
Cancer 9.2.3.1.2. Psoriasis 9.2.3.1.3.
Acne 9.2.3.2. Market Drivers 9.2.3.3.
Historical and Current Market Trends
(2018-2023) 9.2.3.4. Market Breakup by
Type 9.2.3.5. Market Breakup by
End-User 9.2.3.6. Market Breakup by
Application 9.2.3.7. Key Players 9.2.3.8.
Market Forecast (2024-2032) 9.2.3.9. Recent
Investments 9.2.3.9.1. Government
Investments 9.2.3.9.2. Private
Investments 9.2.3.10. Regulatory Approval
Process 9.2.3.11. Pricing Analysis
9.2.4. Italy 9.2.4.1. Patient Cases by
Indication 9.2.4.1.1. Skin Cancer 9.2.4.1.2.
Psoriasis 9.2.4.1.3. Acne 9.2.4.2.
Market Drivers
18
Table of Contents
9.2.4.3. Historical and Current Market Trends
(2018-2023) 9.2.4.4. Market Breakup by
Type 9.2.4.5. Market Breakup by
End-User 9.2.4.6. Market Breakup by
Application 9.2.4.7. Key Players 9.2.4.8.
Market Forecast (2024-2032) 9.2.4.9. Recent
Investments 9.2.4.9.1. Government
Investments 9.2.4.9.2. Private
Investments 9.2.4.10. Regulatory Approval
Process 9.2.4.11. Pricing Analysis
9.2.5. Spain 9.2.5.1. Patient Cases by
Indication 9.2.5.1.1. Skin Cancer 9.2.5.1.2.
Psoriasis 9.2.5.1.3. Acne 9.2.5.2.
Market Drivers 9.2.5.3. Historical and Current
Market Trends (2018-2023) 9.2.5.4. Market
Breakup by Type 9.2.5.5. Market Breakup by
End-User 9.2.5.6. Market Breakup by
Application 9.2.5.7. Key Players 9.2.5.8.
Market Forecast (2024-2032) 9.2.5.9. Recent
Investments 9.2.5.9.1. Government
Investments 9.2.5.9.2. Private
Investments 9.2.5.10. Regulatory Approval
Process 9.2.5.11. Pricing Analysis
9.2.6. Others
19
Table of Contents
9.2.6.1. Historical and Current Market Trends
(2018-2023) 9.2.6.2. Market Forecast
(2024-2032) 9.3. Asia Pacific 9.3.1.
China 9.3.1.1. Market Drivers 9.3.1.2.
Historical and Current Market Trends
(2018-2023) 9.3.1.3. Market Breakup by
Type 9.3.1.4. Market Breakup by
End-User 9.3.1.5. Market Breakup by
Application 9.3.1.6. Key Players 9.3.1.7.
Market Forecast (2024-2032) 9.3.1.8. Recent
Investments 9.3.1.8.1. Government
Investments 9.3.1.8.2. Private
Investments 9.3.1.9. Regulatory Approval
Process 9.3.1.10. Pricing Analysis
9.3.2. Japan 9.3.2.1. Patient Cases by
Indication 9.3.2.1.1. Skin Cancer 9.3.2.1.2.
Psoriasis 9.3.2.1.3. Acne 9.3.2.2.
Market Drivers 9.3.2.3. Historical and Current
Market Trends (2018-2023) 9.3.2.4. Market
Breakup by Type 9.3.2.5. Market Breakup by
End-User 9.3.2.6. Market Breakup by
Application 9.3.2.7. Key Players 9.3.2.8.
Market Forecast (2024-2032) 9.3.2.9. Recent
Investments
20
Table of Contents
9.3.2.9.1. Government Investments 9.3.2.9.2.
Private Investments 9.3.2.10. Regulatory
Approval Process 9.3.2.11. Pricing Analysis
9.3.3. India 9.3.3.1. Market
Drivers 9.3.3.2. Historical and Current Market
Trends (2018-2023) 9.3.3.3. Market Breakup by
Type 9.3.3.4. Market Breakup by
End-User 9.3.3.5. Market Breakup by
Application 9.3.3.6. Key Players 9.3.3.7.
Market Forecast (2024-2032) 9.3.3.8. Recent
Investments 9.3.3.8.1. Government
Investments 9.3.3.8.2. Private
Investments 9.3.3.9. Regulatory Approval
Process 9.3.3.10. Pricing Analysis 9.3.4.
South Korea 9.3.4.1. Market
Drivers 9.3.4.2. Historical and Current Market
Trends (2018-2023) 9.3.4.3. Market Breakup by
Type 9.3.4.4. Market Breakup by
End-User 9.3.4.5. Market Breakup by
Application 9.3.4.6. Key Players 9.3.4.7.
Market Forecast (2024-2032) 9.3.4.8. Recent
Investments 9.3.4.8.1. Government
Investments 9.3.4.8.2. Private
Investments 9.3.4.9. Regulatory Approval
Process 9.3.4.10. Pricing Analysis
21
Table of Contents
9.3.5. Australia 9.3.5.1. Market
Drivers 9.3.5.2. Historical and Current Market
Trends (2018-2023) 9.3.5.3. Market Breakup by
Type 9.3.5.4. Market Breakup by
End-User 9.3.5.5. Market Breakup by
Application 9.3.5.6. Key Players 9.3.5.7.
Market Forecast (2024-2032) 9.3.5.8. Recent
Investments 9.3.5.8.1. Government
Investments 9.3.5.8.2. Private
Investments 9.3.5.9. Regulatory Approval
Process 9.3.5.10. Pricing Analysis 9.3.6.
Indonesia 9.3.6.1. Market Drivers 9.3.6.2.
Historical and Current Market Trends
(2018-2023) 9.3.6.3. Market Breakup by
Type 9.3.6.4. Market Breakup by
End-User 9.3.6.5. Market Breakup by
Application 9.3.6.6. Key Players 9.3.6.7.
Market Forecast (2024-2032) 9.3.6.8. Recent
Investments 9.3.6.8.1. Government
Investments 9.3.6.8.2. Private
Investments 9.3.6.9. Regulatory Approval
Process 9.3.6.10. Pricing Analysis 9.3.7.
Others 9.3.7.1. Historical and Current Market
Trends (2018-2023) 9.3.7.2. Market Forecast
(2024-2032)
22
Table of Contents
9.4. Latin America 9.4.1. Brazil 9.4.1.1.
Market Drivers 9.4.1.2. Historical and
Current Market Trends (2018-2023) 9.4.1.3.
Market Breakup by Type 9.4.1.4. Market Breakup
by End-User 9.4.1.5. Market Breakup by
Application 9.4.1.6. Key Players 9.4.1.7.
Market Forecast (2024-2032) 9.4.1.8. Recent
Investments 9.4.1.8.1. Government
Investments 9.4.1.8.2. Private
Investments 9.4.1.9. Regulatory Approval
Process 9.4.1.10. Pricing Analysis 9.4.2.
Mexico 9.4.2.1. Market Drivers 9.4.2.2.
Historical and Current Market Trends
(2018-2023) 9.4.2.3. Market Breakup by
Type 9.4.2.4. Market Breakup by
End-User 9.4.2.5. Market Breakup by
Application 9.4.2.6. Key Players 9.4.2.7.
Market Forecast (2024-2032) 9.4.2.8. Recent
Investments 9.4.2.8.1. Government
Investments 9.4.2.8.2. Private
Investments 9.4.2.9. Regulatory Approval
Process 9.4.2.10. Pricing Analysis 9.4.3.
Others 9.4.3.1. Historical and Current Market
Trends (2018-2023)
23
Table of Contents
9.4.3.2. Market Forecast (2024-2032) 9.5.
Middle East 9.5.1.1. Market Drivers 9.5.1.2.
Historical and Current Market Trends
(2018-2023) 9.5.1.3. Market Breakup by
Type 9.5.1.4. Market Breakup by
End-User 9.5.1.5. Market Breakup by
Application 9.5.1.6. Market Breakup by
Country 9.5.1.7. Key Players 9.5.1.8.
Market Forecast (2024-2032) 9.5.1.9. Recent
Investments 9.5.1.9.1. Government
Investments 9.5.1.9.2. Private
Investments 9.5.1.10. Regulatory Approval
Process 9.5.1.11. Pricing Analysis 9.6.
Africa 9.6.1.1. Market Drivers 9.6.1.2.
Historical and Current Market Trends
(2018-2023) 9.6.1.3. Market Breakup by
Type 9.6.1.4. Market Breakup by
End-User 9.6.1.5. Market Breakup by
Application 9.6.1.6. Market Breakup by
Country 9.6.1.7. Key Players 9.6.1.8.
Market Forecast (2024-2032) 9.6.1.9. Recent
Investments 9.6.1.9.1. Government
Investments 9.6.1.9.2. Private
Investments 9.6.1.10. Regulatory Approval
Process 9.6.1.11. Pricing Analysis 9.7.
Attractive Investment Proposition by Region
24
Table of Contents
10. Technology Analysis 10.1. Overview of
Different Technologies 10.2. Technology wise
Dermatology Applications 10.3. Time to Market
for New Product 10.4. Key Technology
Trends 10.4.1. Laser Technology
Advancements 10.4.2. Light-Based
Therapies 10.4.3. Advanced Topical Drug
Delivery Systems 11. Government Regulations
and Strategies 11.1. Medical Device Regulation
(MDR) 11.2. CE Marking (European Union)
11.3. ISO Standards Compliance 11.4.
Health Technology Assessment (HTA) 12. Global
Dermatology Devices Market - Industry
Analysis 12.1. Drivers, Restraints, and
Opportunities 12.1.1. Overview 12.1.2.
Drivers 12.1.2.1. Increasing Prevalence of
Skin Disorders 12.1.2.2. Growing Aging
Population 12.1.2.3. Rising Awareness and
Demand for Aesthetic Procedures 12.1.3.
Restraints 12.1.3.1. High Costs of
Dermatological Procedures 12.1.3.2. Stringent
Regulatory Approval Processes 12.1.3.3. Risk
of Adverse Events and Complications 12.1.4.
Opportunities 12.1.4.1. Technological
Innovations 12.1.4.2. Expansion in Emerging
Markets 12.1.4.3. Personalized Medicine and
Treatment Modalities
25
Table of Contents
12.1.5. Impact Analysis 12.2. Porters Five
Forces Analysis 12.2.1. Overview 12.2.2.
Bargaining Power of Buyers 12.2.3. Bargaining
Power of Suppliers 12.2.4. Degree of
Competition 12.2.5. Threat of New
Entrants 12.2.6. Threat of Substitutes 12.3.
Value Chain Analysis 13. Global Dermatology
Devices Market - Competitive Landscape 13.1.
Overview 13.2. Market Structure 13.3.
Market Share by Key Players 13.4. Market
Player Positioning 13.5. Top Winning
Strategies 13.6. Competitive Dashboard 13.7.
Company Evaluation Quadrant 14. Profiles of
Key Players 14.1. Abbott Diagnostics 14.1.1.
Business Overview 14.1.2. Products
Offered 14.1.3. Business Strategies 14.1.3.1.
Marketing Strategy 14.1.3.2. Product
Strategy 14.1.3.3. Channel Strategy 14.1.4.
Financials 14.1.5. SWOT Analysis 14.1.6.
Major News and Events 14.2. Strata Skin
Sciences
26
Table of Contents
14.2.1. Business Overview 14.2.2. Products
Offered 14.2.3. Business Strategies 14.2.3.1.
Marketing Strategy 14.2.3.2. Product
Strategy 14.2.3.3. Channel Strategy 14.2.4.
Financials 14.2.5. SWOT Analysis 14.2.6.
Major News and Events 14.3. Roche
Diagnostics 14.3.1. Business Overview 14.3.2.
Products Offered 14.3.3. Business
Strategies 14.3.3.1. Marketing
Strategy 14.3.3.2. Product Strategy 14.3.3.3.
Channel Strategy 14.3.4. Financials 14.3.5.
SWOT Analysis 14.3.6. Major News and
Events 14.4. Alma Lasers GmbH 14.4.1.
13.4.1 Business Overview 14.4.2. Products
Offered 14.4.3. Business Strategies 14.4.3.1.
Marketing Strategy 14.4.3.2. Product
Strategy 14.4.3.3. Channel Strategy 14.4.4.
SWOT Analysis 14.4.5. Major News and
Events 14.5. Cutera, Inc. 14.5.1. Business
Overview 14.5.2. Products Offered 14.5.3.
Business Strategies
27
Table of Contents
14.5.3.1. Marketing Strategy 14.5.3.2.
Product Strategy 14.5.3.3. Channel
Strategy 14.5.4. Financials 14.5.5. SWOT
Analysis 14.5.6. Major News and Events 14.6.
Syneron Medical Ltd. 14.6.1. Business
Overview 14.6.2. Products Offered 14.6.3.
Business Strategies 14.6.3.1. Marketing
Strategy 14.6.3.2. Product Strategy 14.6.3.3.
Channel Strategy 14.6.4. SWOT
Analysis 14.6.5. Major News and Events 14.7.
3Gen 14.7.1. Business Overview 14.7.2.
Products Offered 14.7.3. Business
Strategies 14.7.3.1. Marketing
Strategy 14.7.3.2. Product Strategy 14.7.3.3.
Channel Strategy 14.7.4. SWOT
Analysis 14.7.5. Major News and Events 14.8.
Aesthetic Group 14.8.1. Business
Overview 14.8.2. Products Offered 14.8.3.
Business Strategies 14.8.3.1. Marketing
Strategy 14.8.3.2. Product Strategy 14.8.3.3.
Channel Strategy 14.8.4. SWOT Analysis
28
Table of Contents

• 14.8.5. Major News and Events
• 14.9. Lumenis, Ltd.
• 14.9.1. Business Overview
• 14.9.2. Products Offered
• 14.9.3. Business Strategies
• 14.9.3.1. Marketing Strategy
• 14.9.3.2. Product Strategy
• 14.9.3.3. Channel Strategy
• 14.9.4. SWOT Analysis
• 14.9.5. Major News and Events
• 14.10. Genesis Biosystems, Inc.
• 14.10.1. Business Overview
• 14.10.2. Product Portfolio
• 14.10.3. Business Strategies
• 14.10.3.1. Marketing Strategy
• 14.10.3.2. Product Strategy
• 14.10.3.3. Channel Strategy
• 14.10.4. SWOT Analysis
• 14.10.5. Major News and Events

29
Partial List of Clients
30
Partial List of Clients
31
Disclaimer

• 2024 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

32
Contact Us
Visit us at
https//www.imarcgroup.com
1-631-791-1145
sales_at_imarcgroup.com
Stay With Us